Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Mutel

Ahmet Turgut Mutel, Napanee CA

Patent application numberDescriptionPublished
20090105412Polyamides for vehicular parts - Polyamides made from a combination of adipic acid, terephthalic acid and 1,6-hexanediamine in specified proportions have excellent salt stress corrosion cracking resistance. These polyamides are especially useful for vehicular parts that are exposed to contact with salts such as sodium chloride or calcium chloride that are used, for instance, for melting ice and/or snow on roadways.04-23-2009

Vincent Mutel, Geneva CH

Patent application numberDescriptionPublished
20090197897Novel Oxadiazole Derivatives and Their Use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors - The present invention relates to new compounds which are Oxadiazole derivatives of formula (I) wherein B, P, Q, W, R08-06-2009
20090215822Substituted Oxadiazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate Receptors - The present invention relates to new compounds which are Oxadiazole derivatives of formula (I) wherein B, P, Q, W, R08-27-2009
201001666551, 4-DISUBSTITUTED 3-CYANO-PYRIDONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2-RECEPTORS - The present invention relates to novel compounds, in particular novel pyridinone derivatives according to Formula (I)07-01-2010

Patent applications by Vincent Mutel, Geneva CH

Vincent Mutel, Plan-Les-Ouates CH

Patent application numberDescriptionPublished
20110319287MODULATOR ASSAY - The present invention relates inter alia to methods for identifying modulators of tumour necrosis factor (TNF) signalling. In one aspect, the method involves identifying an agent that modulates a signalling pathway mediated by TNF, comprising the steps of providing a host cell comprising TNF receptor 1 (TNFR1)-associated death domain (TRADD) linked to a reporter molecule, and determining at least one cellular characteristic detectable by the reporter molecule in the host cell in the presence of TNF and in the presence and absence of a candidate modulator. The invention is suitable for high-throughput screening (HTS) and high-content screening (HCS), or a combination of HTS and HCS.12-29-2011